Clinical Trial Update: Live Enterovirus Vaccine and Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 trial of a live enterovirus vaccine in individuals with Type 1 diabetes or at risk has completed, with results posted in July 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterovirus Infection
• Prediabetes
• Type 1 Diabetes Mellitus

Drugs mentioned

• Live Enterovirus Vaccine (Enterovirus vaccine, live attenuated)

Snippet

Sponsor: Tampere University | Conditions: Enterovirus Infection, Type 1 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2024-07-18